XML 51 R35.htm IDEA: XBRL DOCUMENT
v3.23.1

CAPITAL STOCK (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2023
Equity [Abstract] |
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS | At March 31, 2023, 2022, and 2021 outstanding and exercisable stock purchase warrants consisted of the following: SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS
|  | Number of Shares |  |  | Weighted Averaged Exercise Price |  |  | Weighted Average Life Remaining (Years) |
Outstanding at March 31, 2020 |  |  | 8,504,372 |  |  | $ | 2.10 |  |  |  | 3.60 |
Granted |  |  | 2,925,204 |  |  |  | 2.31 |  |  |  | 2.47 |
Exercised |  |  | (7,821,631 | ) |  |  | 2.08 |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2021 |  |  | 3,607,945 |  |  | $ | 2.31 |  |  |  | 3.24 |
Exercisable at March 31, 2021 |  |  | 3,179,730 |  |  | $ | 2.27 |  |  |  | 3.05 |
SCHEDULE OF OUTSTANDING AND EXERCISABLE STOCK PURCHASE WARRANTS
|  | Number of Shares |  |  | Weighted Averaged Exercise Price |  |  | Weighted Average Life Remaining (Years) |
Outstanding at March 31, 2021 |  |  | 3,607,945 |  |  | $ | 2.31 |  |  |  | 3.24 |
Granted |  |  | 200,000 |  |  |  | 0.01 |  |  |  | 3.92 |
Exercised |  |  | (874,190 | ) |  |  | 1.76 |  |  |  | - |
Forfeited or cancelled |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at March 31, 2022 |  |  | 2,933,755 |  |  | $ | 2.32 |  |  |  | 2.29 |
Exercisable at March 31, 2022 |  |  | 2,933,755 |  |  | $ | 2.32 |  |  |  | 2.29 |
|  | Number of Shares |  |  | Weighted Averaged Exercise Price |  |  | Weighted Average Life Remaining (Years) |
Outstanding at March 31, 2022 |  |  | 2,933,755 |  |  | $ | 2.32 |  |  |  | 2.29 |
Granted |  |  | 150,000 |  |  |  | 0.01 |  |  |  | 4.5 |
Exercised |  |  | (300,003 | ) |  |  | 0.34 |  |  |  | - |
Forfeited or cancelled |  |  | (322,806 | ) |  |  | 2.00 |  |  |  | - |
Outstanding at March 31, 2023 |  |  | 2,460,946 |  |  | $ | 2.46 |  |  |  | 1.59 |
Exercisable at March 31, 2023 |  |  | 2,460,946 |  |  | $ | 2.46 |  |  |  | 1.59 |
As of March 31, 2023, we had 2,460,946 warrants outstanding. Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (2) warrants to purchase 1,448,758 shares of our Common Stock at an exercise price of $2.00 per share consisting of 16% of the warrants until August 2024, and 84% until February 2026; (3) warrants to purchase 474,966 shares of Common Stock at an exercise price of $2.40 until September 2024; (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025, and (5) warrants to purchase 150,000 shares of Common Stock at an exercise price of $6.72 until February 2024.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration